Home : DrugWatch : Valium : Wikipedia : Flumazenil

Wikipedia - Flumazenil

Flumazenil
Systematic (IUPAC) name
ethyl 12-fluoro- 8-methyl- 9-oxo- 2,4,8- triazatricyclo [8.4.0.02,6] tetradeca- 1(10),3,5,11,13- pentaene- 5-carboxylate
Identifiers
CAS number 78755-81-4
ATC code V03AB25
PubChem CID 3373
DrugBank APRD00974
ChemSpider 3256
Chemical data
Formula C15H14FN3O3 
Mol. mass 303.288 g/mol
Synonyms ethyl 8-fluoro- 5,6-dihydro- 5-methyl- 6-oxo- 4H- imidazo [1,5-a] [1,4] benzodiazepine- 3-carboxylate
Pharmacokinetic data
Metabolism Hepatic
Half-life 7-15 min (initial)
20-30 min (brain)
40-80 min (terminal)
Excretion Urine 90-95%
Feces 5-10%
Therapeutic considerations
Pregnancy cat. B3(AU) C
Legal status
Routes Intravenous
 YesY(what is this?)  (verify)
A vial of flumazenil solution for injection

Flumazenil (also known as flumazepil, code name Ro 15-1788, trade names Anexate, Lanexat, Mazicon, Romazicon) is a benzodiazepine antagonist.

It was introduced in 1987 by Hoffmann-La Roche under the trade name Anexate.

Contents

[edit] Uses

Flumazenil is of benefit in patients who become excessively drowsy after benzodiazepines are used for either diagnostic or therapeutic procedures.[1]

It has been used as an antidote in the treatment of benzodiazepine overdoses.[1] It reverses the effects of benzodiazepines by competitive inhibition at the benzodiazepine binding site on the GABAA receptor. There are many complications that must be taken into consideration when used in the acute care setting.[1]

It has been found to be effective in overdoses of non-benzodiazepine sleep enhancers, namely zolpidem and zaleplon.[2]

It has also been used in hepatic encephalopathy, though results have been mixed.[3][4]

The onset of action is rapid and usually effects are seen within one to two minutes. The peak effect is seen at six to ten minutes. The recommended dose for adults is 200 μg every 1–2 minutes until the effect is seen, to a maximum of 3 mg per hour. It is available as a clear, colourless solution for intravenous injection, containing 500 μg in 5 mL.

Many benzodiazepines (including midazolam) have longer half-lives than flumazenil. Therefore, repeat doses of flumazenil may be required to prevent recurrent symptoms of overdosage once the initial dose of flumazenil wears off. It is hepatically metabolised to inactive compounds which are excreted in the urine. Subjects who are physically dependent on benzodiazepines may suffer benzodiazepine withdrawal symptoms, including seizure, upon administration of flumazenil.

It is not recommended for routine use in those with a decreased level of consciousness.[5]

[edit] PET radioligand

Radiolabeled with the radioactive isotope carbon-11 flumazenil may be used as a radioligand in neuroimaging with positron emission tomography to visualize the distribution of GABAA receptors in the human brain.[6]

[edit] Clinical pharmacology

Flumazenil, an imidazobenzodiazepine derivative, antagonizes the actions of benzodiazepines on the central nervous system. Flumazenil competitively inhibits the activity at the benzodiazepine recognition site on the GABA / benzodiazepine receptor complex. Flumazenil is a weak partial agonist in some animal models of activity, but has little or no agonist activity in humans.

Flumazenil does not antagonize the central nervous system effects of drugs affecting GABA-ergic neurons by means other than the benzodiazepine receptor (including ethanol, barbiturates, or general anesthetics) and does not reverse the effects of opioids.

In animals pretreated with high doses of benzodiazepines over several weeks, Flumazenil injection elicited symptoms of benzodiazepine withdrawal, including seizures. A similar effect was seen in adult human subjects.

[edit] Pharmacodynamics

Intravenous Flumazenil has been shown to antagonize sedation, impairment of recall, psychomotor impairment and ventilatory depression produced by benzodiazepines in healthy human volunteers.

The duration and degree of reversal of sedative benzodiazepine effects are related to the dose and plasma concentrations of Flumazenil.

[edit] Chemistry

Flumazenil Rxn.png

Gerecke, M.; Hunkeler, W.; Kyburz, E.; Mohler, H.; Pieri, L.; Pole, P.; 1982, U.S. Patent 4,316,839.

[edit] See also

[edit] References

  1. ^ a b c Goldfrank, Lewis R. (2002). Goldfrank's toxicologic emergencies. New York: McGraw-Hill Medical Publ. Division. ISBN 0-07-136001-8. http://books.google.com/?id=HVYyRsuUEc0C&pg=PA948&dq=flumazenil+not+to+be+used+in+overdose. 
  2. ^ Nelson, Lewis H.; Flomenbaum, Neal; Goldfrank, Lewis R.; Hoffman, Robert Louis; Howland, Mary Deems; Neal A. Lewin (2006). Goldfrank's toxicologic emergencies. New York: McGraw-Hill, Medical Pub. Division. ISBN 0-07-147914-7. 
  3. ^ Goulenok C, Bernard B, Cadranel JF, et al. (March 2002). "Flumazenil vs. placebo in hepatic encephalopathy in patients with cirrhosis: a meta-analysis". Aliment. Pharmacol. Ther. 16 (3): 361–72. doi:10.1046/j.1365-2036.2002.01191.x. PMID 11876688. http://www3.interscience.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=0269-2813&date=2002&volume=16&issue=3&spage=361. 
  4. ^ Als-Nielsen B, Gluud LL, Gluud C (2004). "Benzodiazepine receptor antagonists for hepatic encephalopathy". Cochrane Database Syst Rev (2): CD002798. doi:10.1002/14651858.CD002798.pub2. PMID 15106178. 
  5. ^ Wood, Lawrence D. H.; Hall, Jesse B.; Schmidt, Gregory D. 1952 (2005). Principles of critical care. McGraw-Hill Professional. ISBN 0-07-141640-4. http://books.google.com/?id=Ss7gzGwk78gC&pg=RA11-PA1505&lpg=RA11-PA1505&dq=flumazenil+not+recommended+in+overdose. 
  6. ^ Alexander Hammers, Matthias J. Koepp, Mark P. Richardson, Rene Hurlemann, David J. Brooks & John S. Duncan (June 2003). "Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI. A PET study of 44 patients". Brain 126 (Pt 6): 1300–1308. doi:10.1093/brain/awg138. PMID 12764053. http://brain.oxfordjournals.org/cgi/content/abstract/126/6/1300. 

[edit] Other

[edit] External links


v â€¢ d â€¢ e
Benzodiazepine derivatives (N05BA, N05CD)
1,4-Benzodiazepines

Bromazepam Â· Camazepam Â· Carburazepam Â· Chlordiazepoxide Â· Cinolazepam Â· Clonazepam Â· Clorazepate Â· Cyprazepam Â· Delorazepam Â· Demoxepam Â· Devazepide* Â· Diazepam Â· Doxefazepam Â· Elfazepam Â· Ethyl carfluzepate Â· Ethyl dirazepate Â· Ethyl loflazepate Â· Fletazepam Â· Fludiazepam Â· Flunitrazepam Â· Flurazepam Â· Flutemazepam Â· Flutoprazepam Â· Fosazepam Â· Gidazepam Â· Halazepam Â· Iclazepam Â· Ketazolam Â· Lorazepam Â· Lormetazepam Â· Meclonazepam Â· Medazepam Â· Menitrazepam Â· Metaclazepam Â· Motrazepam Â· Nimetazepam Â· Nitrazepam Â· Nitrazepate Â· Nordazepam Â· Nortetrazepam Â· Oxazepam Â· Phenazepam Â· Pinazepam Â· Pivoxazepam Â· Prazepam Â· Proflazepam Â· Quazepam Â· QH-II-66 Â· Reclazepam Â· Sulazepam Â· Temazepam Â· Tetrazepam Â· Tifluadom* Â· Tolufazepam Â· Tuclazepam Â· Uldazepam
1,5-Benzodiazepines
2,3-Benzodiazepines *
Triazolobenzodiazepines
Imidazobenzodiazepines

Bretazenil Â· Climazolam Â· Flumazenil Â· Imidazenil Â· L-655,708 Â· Loprazolam Â· Midazolam Â· PWZ-029 Â· Ro15-4513 Â· Ro48-6791 Â· Ro48-8684 Â· Sarmazenil Â· SH-053-R-CH3-2′F
Oxazolobenzodiazepines
Thienodiazepines
Pyridodiazepines
Pyrazolodiazepines

Razobazam* Â· Ripazepam Â· Zolazepam Â· Zomebazam
Pyrrolodiazepines
Benzodiazepine prodrugs
 * atypical activity profile (not GABAA receptor ligands)
v â€¢ d â€¢ e
Antidotes (V03AB)
Nervous system
Atropine# Â· Biperiden Â· Diazepam# Â· Oximes (Pralidoxime, Obidoxime) Â· see also Cholinesterase
Cyprodenate Â· Flumazenil
Cardiovascular
Other
Paracetamol toxicity (Acetaminophen)
Other
Emetic
#WHO-EM. ‡Withdrawn from market. CLINICAL TRIALS: †Phase III. §Never to phase III
Retrieved from "http://en.wikipedia.org/wiki/Flumazenil"

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Flumazenil".

Need A Valium Attorney?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury

Your Friend's Email Address

Your Email Address

Type a Message (optional)


Want to contact a Valium attorney in District of Columbia?...Get a free case evaluation from one of our Valium attorneys in District of Columbia now.

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Valium Case - Submit Your Information Below

Do you need legal assistance with your Valium case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * DrugWatch: Valium Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.
This form is secure and encrypted. More information about secure forms and your privacy here.